Centene Reaffirms Full Year Guidance, Optimistic on Medicare Performance
Company Announcements

Centene Reaffirms Full Year Guidance, Optimistic on Medicare Performance

Centene ( (CNC) ) has provided an update.

On September 10, 2024, Centene Corporation’s senior management will meet with investors to reaffirm their full year adjusted EPS guidance of over $6.80, noting a shift of 20 to 30 cents from Q3 to Q4, with third-quarter adjusted EPS projected between $1.31 and $1.41. They are also optimistic about improvements in their Medicare Advantage stars program performance. The Company emphasizes the use of non-GAAP financial measures for a more consistent evaluation of performance, although these are not meant to replace GAAP measures.

For detailed information about CNC stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyCentene put volume heavy and directionally bearish
TipRanks Auto-Generated NewsdeskCentene to Reaffirm Financial Guidance at Healthcare Conference
TheFlyCentene price target lowered to $91 from $93 at Wells Fargo
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App